A recent study found that BC200 could regulate CUEDC2 expression and the PTEN/AKT/p21 pathway by functioning as a ceRNA for sponging miR-619-5p to inhibit glioma progression [33]. Here, BCYRN1 is linked to central nervous system cancer.